Organization Name Apellis PharmaceuticalsAnnounced Date Feb 12, 2016 Funding Type Series D Funding Stage Late Stage Venture Money Raised
- Cormorant Asset Management
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles.
Investor Name | Partners |
---|---|
venBio Partners | |
Morningside Group | |
Hillhouse Investment | |
Epidarex Capital | |
Cormorant Asset Management | |
Aju IB Investment |
PRNewswire All — Apellis Completes $47 Million Series D Financing
VentureDeal — Apellis Pharma Accepts $32 Million Equity VC